Showing results (11-20 of 28) with videos related to
Sort By:
Pageof 3
Journal of Nanobiotechnology|October 2, 2025
Magnetically navigated nano-PROTAC ameliorates acute lung injurySheng Chen, Enen Chen, Jianfen Su, et al.Clinical Pharmacology in Drug Development|May 14, 2024
Bioequivalence Study of Atenolol Tablets in Healthy Chinese Subjects Under Fasting and Fed ConditionsYongtao Li, Yingying Huang, Xihua Fu, et al.ACS Applied Materials & Interfaces|September 21, 2024
Artificial Neutrophil-Mediated CEBPA-saRNA Delivery to Ameliorate ALI/ARDSLingmin Zhang, Sheng Chen, ZhouYikang Zheng, et al.Frontiers in Pharmacology|July 1, 2022
Dose-Effect Relationship of Chitosan and Danshen Combined Injection for Fallopian Tube RecanalizationChen Huang, Qiong Wu, Jiabin Liang, et al.International Journal of Nanomedicine|December 25, 2023
Liver-Specific Ionizable Lipid Nanoparticles Mediated Efficient RNA Interference to Clear "Bad Cholesterol"Chuangjia Huang, Yu Zhang, Jianfen Su, et al.Mikrochimica Acta|December 28, 2024
Rapid evaluation of hepatocellular carcinoma by detecting plasma exosomes with time-resolved fluorescence immunochromatographic test stripsJiaming Li, Jianfen Su, Minghui Li, et al.International Journal of Pharmaceutics: X|May 22, 2026
Acidic-responsive nano liposomes potentiate in situ dual immunotherapy on lung cancer by codelivering antagonistic peptide and agonistYinshan Lin, Lu Liang, Le Wang, et al.International Journal of Nanomedicine|January 2, 2024
Cell Membrane-Camouflaged Nanoparticles Mediated Nucleic Acids DeliveryYinshan Lin, Xiaoling Guan, Jianfen Su, et al.Clinical Pharmacology in Drug Development|May 21, 2023
Pharmacokinetics, Bioequivalence, and Safety Evaluation of 2 Formulations of 10-mg Rivaroxaban Tablets: A 4-Period Crossover TrialCanhua Zhang, Zihan Shen, Jianhao Li, et al.Aging|February 12, 2024
Identification of crucial anoikis-related genes as novel biomarkers and potential therapeutic targets for lung adenocarcinoma via bioinformatic analysis and experimental verificationJie Wu, Yuting Zhang, Guoxing You, et al.Pageof 3